These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 35254400)
1. Transcriptomic Profiling of MSI-H/dMMR Gastrointestinal Tumors to Identify Determinants of Responsiveness to Anti-PD-1 Therapy. Chida K; Kawazoe A; Suzuki T; Kawazu M; Ueno T; Takenouchi K; Nakamura Y; Kuboki Y; Kotani D; Kojima T; Bando H; Mishima S; Kuwata T; Sakamoto N; Watanabe J; Mano H; Ikeda M; Shitara K; Endo I; Nakatsura T; Yoshino T Clin Cancer Res; 2022 May; 28(10):2110-2117. PubMed ID: 35254400 [TBL] [Abstract][Full Text] [Related]
2. A Low Tumor Mutational Burden and Chida K; Kawazoe A; Kawazu M; Suzuki T; Nakamura Y; Nakatsura T; Kuwata T; Ueno T; Kuboki Y; Kotani D; Kojima T; Taniguchi H; Mano H; Ikeda M; Shitara K; Endo I; Yoshino T Clin Cancer Res; 2021 Jul; 27(13):3714-3724. PubMed ID: 33926917 [TBL] [Abstract][Full Text] [Related]
3. Genomic and transcriptomic characterization of heterogeneous immune subgroups of microsatellite instability-high colorectal cancers. Kim JH; Seo MK; Lee JA; Yoo SY; Oh HJ; Kang H; Cho NY; Bae JM; Kang GH; Kim S J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34903553 [TBL] [Abstract][Full Text] [Related]
4. Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade. Abida W; Cheng ML; Armenia J; Middha S; Autio KA; Vargas HA; Rathkopf D; Morris MJ; Danila DC; Slovin SF; Carbone E; Barnett ES; Hullings M; Hechtman JF; Zehir A; Shia J; Jonsson P; Stadler ZK; Srinivasan P; Laudone VP; Reuter V; Wolchok JD; Socci ND; Taylor BS; Berger MF; Kantoff PW; Sawyers CL; Schultz N; Solit DB; Gopalan A; Scher HI JAMA Oncol; 2019 Apr; 5(4):471-478. PubMed ID: 30589920 [TBL] [Abstract][Full Text] [Related]
6. A Phase II Study of Avelumab Monotherapy in Patients with Mismatch Repair-Deficient/Microsatellite Instability-High or POLE-Mutated Metastatic or Unresectable Colorectal Cancer. Kim JH; Kim SY; Baek JY; Cha YJ; Ahn JB; Kim HS; Lee KW; Kim JW; Kim TY; Chang WJ; Park JO; Kim J; Kim JE; Hong YS; Kim YH; Kim TW Cancer Res Treat; 2020 Oct; 52(4):1135-1144. PubMed ID: 32340084 [TBL] [Abstract][Full Text] [Related]
8. Biomarkers of Pathologic Complete Response to Neoadjuvant Immunotherapy in Mismatch Repair-Deficient Colorectal Cancer. Li J; Hu H; Qin G; Bai F; Wu X; Ke H; Zhang J; Xie Y; Wu Z; Fu Y; Zheng H; Gong L; Xie Z; Deng Y Clin Cancer Res; 2024 Jan; 30(2):368-378. PubMed ID: 37906636 [TBL] [Abstract][Full Text] [Related]
9. Performance of Next-Generation Sequencing for the Detection of Microsatellite Instability in Colorectal Cancer With Deficient DNA Mismatch Repair. Ratovomanana T; Cohen R; Svrcek M; Renaud F; Cervera P; Siret A; Letourneur Q; Buhard O; Bourgoin P; Guillerm E; Dorard C; Nicolle R; Ayadi M; Touat M; Bielle F; Sanson M; Le Rouzic P; Buisine MP; Piessen G; Collura A; Fléjou JF; de Reyniès A; Coulet F; Ghiringhelli F; André T; Jonchère V; Duval A Gastroenterology; 2021 Sep; 161(3):814-826.e7. PubMed ID: 33992635 [TBL] [Abstract][Full Text] [Related]
10. Single-cell sequencing reveals the immune microenvironment landscape related to anti-PD-1 resistance in metastatic colorectal cancer with high microsatellite instability. Wu T; Zhang X; Liu X; Cai X; Shen T; Pan D; Liang R; Ding R; Hu R; Dong J; Li F; Li J; Xie L; Wang C; Geng S; Yang Z; Xing L; Li Y BMC Med; 2023 Apr; 21(1):161. PubMed ID: 37106440 [TBL] [Abstract][Full Text] [Related]
16. Association of Consensus Molecular Subtypes and Molecular Markers With Clinical Outcomes in Patients With Metastatic Colorectal Cancer: Biomarker Analyses From LUME-Colon 1. Lenz HJ; Argiles G; Yoshino T; Tejpar S; Ciardiello F; Braunger J; Salnikov AV; Gabrielyan O; Schmid R; Höfler J; Kitzing T; Van Cutsem E Clin Colorectal Cancer; 2021 Mar; 20(1):84-95.e8. PubMed ID: 33041226 [TBL] [Abstract][Full Text] [Related]
17. Subcutaneous envafolimab monotherapy in patients with advanced defective mismatch repair/microsatellite instability high solid tumors. Li J; Deng Y; Zhang W; Zhou AP; Guo W; Yang J; Yuan Y; Zhu L; Qin S; Xiang S; Lu H; Gong J; Xu T; Liu D; Shen L J Hematol Oncol; 2021 Jun; 14(1):95. PubMed ID: 34154614 [TBL] [Abstract][Full Text] [Related]
18. Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study. Zhang B; Song Y; Luo S; Yin X; Li E; Wang H; He Y; Liu Z; Fan Q; Liang X; Shu Y; Liu Y; Xu N; Zhang S; Zhuang Z; Zhang J; Kou X; Wang F; Zhu X; Zeng S; Wang K; Zhong H; Li S; Bai Y; Yu J; Dou Y; Ma T; Liu Q; Huang J Cell Rep Med; 2023 Dec; 4(12):101301. PubMed ID: 38016482 [TBL] [Abstract][Full Text] [Related]
19. Current Strategy to Treat Immunogenic Gastrointestinal Cancers: Perspectives for a New Era. Shimozaki K; Nakayama I; Hirota T; Yamaguchi K Cells; 2023 Mar; 12(7):. PubMed ID: 37048122 [TBL] [Abstract][Full Text] [Related]
20. Clinical responses to PD-1 inhibition and their molecular characterization in six patients with mismatch repair-deficient metastatic cancer of the digestive system. Hirsch D; Gaiser T; Merx K; Weingaertner S; Forster M; Hendricks A; Woenckhaus M; Schubert T; Hofheinz RD; Gencer D J Cancer Res Clin Oncol; 2021 Jan; 147(1):263-273. PubMed ID: 32776177 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]